← brief for 2026-10-09 · Slowing decline

Repurposing SGLT2 Inhibitors Beyond Diabetes: Emerging Roles in Cancer Prevention and Therapy.

Article No results yet Peer reviewed

Key takeaways

This chapter looks at how a common kidney and diabetes drug might help with cancer. It mostly covers tests in animals and cells. It is a review of existing work, not a new study with new results.

Who did this work

Shrestha A · Perez I · Miles J · Lopategui LC · Deb S · Basak D

Source

Article · PubMed, the drug frontier · 2026 Oct 9
https://pubmed.ncbi.nlm.nih.gov/42850458/